These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28281900)

  • 21. Therapeutic inhibition of SGK1 suppresses colorectal cancer.
    Liang X; Lan C; Jiao G; Fu W; Long X; An Y; Wang K; Zhou J; Chen T; Li Y; Xu J; Huang Q; Xu B; Xiao J
    Exp Mol Med; 2017 Nov; 49(11):e399. PubMed ID: 29170478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel targets for anticancer treatment development in colorectal cancer.
    Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
    Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Phosphorylation Consensus Sequences and Endogenous Neuronal Substrates of the Psychiatric Risk Kinase TNIK.
    Wang Q; Amato SP; Rubitski DM; Hayward MM; Kormos BL; Verhoest PR; Xu L; Brandon NJ; Ehlers MD
    J Pharmacol Exp Ther; 2016 Feb; 356(2):410-23. PubMed ID: 26645429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
    Klauck PJ; Bagby SM; Capasso A; Bradshaw-Pierce EL; Selby HM; Spreafico A; Tentler JJ; Tan AC; Kim J; Arcaroli JJ; Purkey A; Messersmith WA; Kuida K; Eckhardt SG; Pitts TM
    BMC Cancer; 2018 Feb; 18(1):136. PubMed ID: 29402316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-metastatic treatment in colorectal cancer: targeting signaling pathways.
    Lemos C; Sack U; Schmid F; Juneja M; Stein U
    Curr Pharm Des; 2013; 19(5):841-63. PubMed ID: 22973955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
    Ji H; Greening DW; Barnes TW; Lim JW; Tauro BJ; Rai A; Xu R; Adda C; Mathivanan S; Zhao W; Xue Y; Xu T; Zhu HJ; Simpson RJ
    Proteomics; 2013 May; 13(10-11):1672-86. PubMed ID: 23585443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the interaction of Aurora kinases and SIRT1 mediated by Wnt signaling pathway in colorectal cancer: A critical review.
    Subramaniyan B; Jagadeesan K; Ramakrishnan S; Mathan G
    Biomed Pharmacother; 2016 Aug; 82():413-24. PubMed ID: 27470380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Triage Trials in Colorectal Cancer.
    O'Hara MH; Hamilton SR; O'Dwyer PJ
    Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies for colorectal cancer.
    Hezel AF; Ryan DP
    Expert Opin Investig Drugs; 2007 Jun; 16(6):867-76. PubMed ID: 17501698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel and Emerging Targeted Therapies of Colorectal Cancer.
    Finnberg N; Gokare P; El-Deiry WS
    Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antrodia cinnamomea induces autophagic cell death via the CHOP/TRB3/Akt/mTOR pathway in colorectal cancer cells.
    Tsai DH; Chung CH; Lee KT
    Sci Rep; 2018 Nov; 8(1):17424. PubMed ID: 30479369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances in Developmental Signaling Pathway Inhibitors for the Treatment of Cancer.
    Hadden MK
    Curr Med Chem; 2015; 22(35):4031-2. PubMed ID: 26630931
    [No Abstract]   [Full Text] [Related]  

  • 33. Considerations on the implementation of MAP4K4 inhibitors as cancer treatment.
    Gonzalez-Montero J; Burotto M
    Expert Opin Ther Targets; 2024 Mar; 28(3):113-115. PubMed ID: 38421000
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeting the Colorectal Cancer Stem Cell.
    Medema JP
    N Engl J Med; 2017 Aug; 377(9):888-890. PubMed ID: 28854096
    [No Abstract]   [Full Text] [Related]  

  • 35. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
    Bordonaro M; Lazarova DL
    World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.
    Zhou W; Tian Y; Gong H; Guo S; Luo C
    Expert Opin Ther Targets; 2014 Aug; 18(8):961-71. PubMed ID: 24946986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The challenge to optimize medical therapy for advanced colorectal cancer.
    Hubbard JM; Grothey A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt442. PubMed ID: 24511110
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeted therapy for metastatic colorectal cancer.
    Price TJ; Tang M; Gibbs P; Haller DG; Peeters M; Arnold D; Segelov E; Roy A; Tebbutt N; Pavlakis N; Karapetis C; Burge M; Shapiro J
    Expert Rev Anticancer Ther; 2018 Oct; 18(10):991-1006. PubMed ID: 30019590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.